Therapeutic Advances in Endocrinology and Metabolism

Papers
(The H4-Index of Therapeutic Advances in Endocrinology and Metabolism is 15. The table below lists those papers that are above that threshold based on CrossRef citation counts [max. 250 papers]. The publications cover those that have been published in the past four years, i.e., from 2021-05-01 to 2025-05-01.)
ArticleCitations
Controversies in the management of active Charcot neuroarthropathy98
The global burden of thyroid cancer in high-income Asia-Pacific: a systematic analysis of the Global Burden of Disease study63
Gender-affirming hormone therapy, mental health, and surgical considerations for aging transgender and gender diverse adults51
Insulin therapy among diabetic patients in rural communities of Sub-Saharan Africa: a perspective review31
Role of epicardial adipose tissue in diabetic cardiomyopathy through the lens of cardiovascular magnetic resonance imaging – a narrative review21
In-person and virtual multidisciplinary intensive lifestyle interventions are equally effective in patients with type 2 diabetes and obesity21
Effect of sodium-glucose cotransporter-2 inhibitors on patients with essential hypertension and pre-hypertension: a meta-analysis20
Differences in adherence to using removable cast walker treatment during daytime and nighttime weight-bearing activities in people with diabetes-related foot ulcers20
Epidemiology, natural history, and diagnosis of metabolic dysfunction-associated fatty liver disease: a comparative review with nonalcoholic fatty liver disease20
Update on genetics and epigenetics in metabolic associated fatty liver disease18
Glycaemic outcomes in people living with diabetes under 65 and over 65 years old using an intermittently scanned continuous glucose monitoring system17
Is there a causal relationship between hypothyroidism and hyponatremia?16
Chronic kidney disease combined with metabolic syndrome is a non-negligible risk factor16
Pheochromocytoma: a changing perspective and current concepts16
Prevalence and associated factors of hyperuricemia among Chinese patients with diabetes: a cross-sectional study15
Design and rationale for the SIB trial: a randomized parallel comparison of semaglutide versus placebo on intestinal barrier function in type 2 diabetes mellitus15
Retraction notice15
0.081938982009888